View full article originally posted on July 30, 2020, by the Wall Street Journal here.
Wall Street Journal | Medical-Device Investment Rises in Second Quarter
Jul 2020
Brian Bock, Lincoln International Managing Director, discusses with the The Wall Street Journal how investments in the medical device sector have been impacted by the #COVID19 pandemic and the expectation that they should rise in the second half of the year.
Summary
-
Brian Bock, Lincoln International Managing Director, discusses with the The Wall Street Journal the state of investments in the medical device sector.
- Sign up to receive Lincoln's perspectives
Contributor
Meet our Senior Team in Healthcare
I enjoy working closely with clients to overcome challenging situations and to develop strategies to meet their business goals.
Dirk-Oliver Löffler
Managing Director | European Co-head Healthcare
FrankfurtRelated Perspectives
What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access
The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More
Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal
The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More
Scrip Asks…What Does 2024 Hold for Biopharma?
James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2024 as part of Scrip’s series. Part One – Business Strategy and Leadership… Read More